Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000815601 | SCV000956062 | uncertain significance | Early-onset Lafora body disease | 2021-12-09 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 656 of the PRDM8 protein (p.Pro656Ser). This variant is present in population databases (rs200471159, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with PRDM8-related conditions. ClinVar contains an entry for this variant (Variation ID: 658722). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004028859 | SCV005012437 | uncertain significance | not specified | 2023-12-21 | criteria provided, single submitter | clinical testing | The c.1966C>T (p.P656S) alteration is located in exon 10 (coding exon 3) of the PRDM8 gene. This alteration results from a C to T substitution at nucleotide position 1966, causing the proline (P) at amino acid position 656 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |